Stock 6696 LIN BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Lin BioScience, Inc.

Equities

6696

TW0006696008

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-04-17 pm EDT 		5-day change 1st Jan Change
70.7 TWD -7.46% Intraday chart for Lin BioScience, Inc. -18.55% -37.98%
2023 Lin BioScience, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
2023 Lin BioScience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI

Business Summary

LIN BIOSCIENCE, INC. is a Taiwan-based company mainly engaged in the development of new pharmaceutical drugs. The Company is in the research and development and clinical trials stage. It has four major drugs in development, including LBS-008, LBS-007, LBS-009 and LBS-002, as well as two technical platforms of RBP4 and CDC7. LBS-008 is developed for dry macular degeneration which belongs to the best-selling drugs, and stel lesions which belongs to orphan drugs. LBS-007 is used in acute leukemia which belongs to orphan drugs, and solid tumors which belongs to the best-selling drugs. LBS-009 is used in non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH) and type 2 diabetes. LBS-002 is developed for primary brain cancer and metastatic brain cancer. RBP4 platform is used for metabolic diseases, and CDC7 platform is used for all cancers.

Managers

Managers TitleAgeSince
Yue Hsin Lin FOU
 Founder 46 16-05-11
Wan Shan Chen DFI
 Director of Finance/CFO 38 16-05-31
Hung Wei Chen COO
 Chief Operating Officer 43 16-06-30
Cheng Chi Wang CTO
 Chief Tech/Sci/R&D Officer - 16-05-31
Hao Yuan Chuang BRD
 Director/Board Member 40 17-11-30

Members of the board

Members of the board TitleAgeSince
Hsien Hua Huang BRD
 Director/Board Member - 18-09-26
San Chien Tu BRD
 Director/Board Member - 18-09-26
Chan Yue Li BRD
 Director/Board Member 52 16-10-12
Yue Hsin Lin FOU
 Founder 46 16-05-11
Cheng Wei Chu BRD
 Director/Board Member - 18-09-26
Fang Ming Hsu BRD
 Director/Board Member - 16-10-12
Hao Yuan Chuang BRD
 Director/Board Member 40 17-11-30
Hung Wei Chen COO
 Chief Operating Officer 43 16-06-30
Hui Chun Wang BRD
 Director/Board Member 78 18-09-26
Wei Jen Liang BRD
 Director/Board Member - 18-09-26

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 78,516,000 78,516,000 ( 100.00 %) 0 100.00 %

Holdings

NameEquities%Valuation
BELITE BIO, INC
68.66%
 17,095,263 68.66% 655,945,241 $

Company contact information

Lin BioScience, Inc.

36/F., No. 68, Section 5 Zhongxiao East Road

110, Taipei

+

http://www.linbioscience.com
address Lin BioScience, Inc.(6696)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
LIN BIOSCIENCE, INC. Stock Lin BioScience, Inc.
-37.98% 185M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+27.94% 676B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+23.58% 554B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.76% 349B
MERCK & CO., INC. Stock Merck & Co., Inc.
+14.56% 318B
ABBVIE INC. Stock AbbVie Inc.
+6.50% 291B
ASTRAZENECA PLC Stock AstraZeneca PLC
+2.96% 210B
NOVARTIS AG Stock Novartis AG
-0.41% 204B
ROCHE HOLDING AG Stock Roche Holding AG
-10.02% 194B
PFIZER, INC. Stock Pfizer, Inc.
-12.10% 144B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 6696 Stock
  4. Company Lin BioScience, Inc.